Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04322955
Title CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition (Cyto-KIK)
Acronym Cyto-KIK
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mark Stein
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.